Guasparini R - Search Results

1

Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old.

Halperin SA, Eastwood B, Barreto L, Mills E, Blatter M, Reisinger K, Bader G, Keyserling H, Roberts EA, Guasparini R, et al. Halperin SA, et al. Among authors: guasparini r. Scand J Infect Dis. 1995;27(3):279-87. doi: 10.3109/00365549509019022. Scand J Infect Dis. 1995. PMID: 8539554 Clinical Trial.

2

Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine.

Halperin SA, Scheifele D, Mills E, Guasparini R, Humphreys G, Barreto L, Smith B. Halperin SA, et al. Among authors: guasparini r. Vaccine. 2003 Jun 2;21(19-20):2298-306. doi: 10.1016/s0264-410x(03)00173-7. Vaccine. 2003. PMID: 12744860 Clinical Trial.

3

Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life.

Halperin SA, Eastwood BJ, Barreto L, Friesen B, Medd L, Meekison W, Guasparini R. Halperin SA, et al. Among authors: guasparini r. Vaccine. 1996 Jun;14(8):767-72. doi: 10.1016/0264-410x(95)00250-5. Vaccine. 1996. PMID: 8817823 Clinical Trial.

4

Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants.

Halperin SA, Davies HD, Barreto L, Guasparini R, Meekison W, Humphreys G, Eastwood BJ. Halperin SA, et al. Among authors: guasparini r. J Pediatr. 1997 Apr;130(4):525-31. doi: 10.1016/s0022-3476(97)70233-6. J Pediatr. 1997. PMID: 9108847 Clinical Trial.

5

Safety and immunogenicity of an acellular pertussis diphtheria tetanus vaccine given as a single injection with Haemophilus influenzae b conjugate vaccine.

Halperin SA, Barreto L, Eastwood BJ, Medd L, Guasparini R, Mills E. Halperin SA, et al. Among authors: guasparini r. Vaccine. 1997 Feb;15(3):295-300. doi: 10.1016/s0264-410x(96)00177-6. Vaccine. 1997. PMID: 9139489 Clinical Trial.

6

Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age.

Halperin SA, Scheifele D, Barreto L, Pim C, Guasparini R, Medd L, Meekison W, Eastwood BJ. Halperin SA, et al. Among authors: guasparini r. Pediatr Infect Dis J. 1999 Sep;18(9):772-9. doi: 10.1097/00006454-199909000-00006. Pediatr Infect Dis J. 1999. PMID: 10493336 Clinical Trial.

7

An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults.

Halperin SA, Smith B, Russell M, Hasselback P, Guasparini R, Skowronski D, Meekison W, Parker R, Lavigne P, Barreto L. Halperin SA, et al. Among authors: guasparini r. Vaccine. 2000 Jan 31;18(14):1312-9. doi: 10.1016/s0264-410x(99)00415-6. Vaccine. 2000. PMID: 10618527 Clinical Trial.

8

Controlled trial of Haemophilus influenzae type B diphtheria toxoid conjugate combined with diphtheria, tetanus and pertussis vaccines, in 18-month-old children, including comparison of arm versus thigh injection.

Scheifele D, Bjornson G, Barreto L, Meekison W, Guasparini R. Scheifele D, et al. Among authors: guasparini r. Vaccine. 1992;10(7):455-60. doi: 10.1016/0264-410x(92)90394-y. Vaccine. 1992. PMID: 1609548 Clinical Trial.

9

Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age.

Gold R, Scheifele D, Barreto L, Wiltsey S, Bjornson G, Meekison W, Guasparini R, Medd L. Gold R, et al. Among authors: guasparini r. Pediatr Infect Dis J. 1994 May;13(5):348-55. doi: 10.1097/00006454-199405000-00004. Pediatr Infect Dis J. 1994. PMID: 8072815 Clinical Trial.

10

Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus B conjugate vaccine administered to infants at two, four and six months of age.

Mills E, Gold R, Thipphawong J, Barreto L, Guasparini R, Meekison W, Cunning L, Russell M, Harrison D, Boyd M, Xie F. Mills E, et al. Among authors: guasparini r. Vaccine. 1998 Apr;16(6):576-85. doi: 10.1016/s0264-410x(97)00241-7. Vaccine. 1998. PMID: 9569468 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page